Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.35 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2553367 | 0.83 | SLC7A5 (0.41) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL4949366 | 0.74 | — | — | |
| SCHEMBL5328465 | 0.70 | HTT (0.40) | CA2MAPK1TDP1CHRM1AKR1A1 | |
| SCHEMBL4954129 | 0.69 | TDP1 (0.40) | SLC1A3SLC1A2SLC1A1GRIK1GRIK2 | |
| Isoleucine SCHEMBL28123461 | 0.67 | SLC7A5 (0.52) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL5328559 | 0.67 | — | — | |
| SCHEMBL1405514 | 0.67 | — | — | |
| SCHEMBL1168875 | 0.66 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL2424284 | 0.66 | — | — | |
| SCHEMBL16678398 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2556051-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | Sumitomo Chemical Company, Limited (JP) | 2013-02-13 | — | — | EP | disclosed |
| EP-2556052-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | Sumitomo Chemical Company, Limited (JP) | 2013-02-13 | — | — | EP | disclosed |
| US-20130035506-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-02-07 | — | — | US | disclosed |
| US-20130023696-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-01-24 | — | — | US | disclosed |
| WO-2011126130-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-10-13 | — | — | WO | disclosed |
| WO-2011126129-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035506-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | AADAT, BCAT2, CBS | SLC7A5 97/4885SLC1A3 50/4885SLC1A2 39/4885 |
| US-20130023696-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | CBS, CTH, BCAT2 | SLC7A5 103/4885SLC1A3 62/4885SLC1A2 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.